WebApr 11, 2024 · 1 equities research analysts have issued 1 year target prices for Citius Pharmaceuticals' shares. Their CTXR share price forecasts range from $6.00 to $6.00. On average, they expect the company's stock price to reach $6.00 in the next year. This suggests a possible upside of 412.8% from the stock's current price. WebNov 1, 2024 · Regular YouTube videos on financial market outlooks, news, ERs, stock research, TA, options trading, & investing. NOT FINANCIAL ADVICE. Potato with a platform.
Spencer Traders Stock on Twitter: "$ctxr,Earnings reports today …
WebApr 6, 2024 · A high-level overview of Citius Pharmaceuticals, Inc. (CTXR) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Web2 days ago · Company Profile CTXR. Business Description. Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, unique prescription products, and stem ... dallas county mediation center
さみだれ on Twitter: "$WULF $EMAN $RIOT $DTC $WW $BUR …
WebJun 21, 2024 · Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) is not the most popular stock in this group but hedge fund interest is still above average. Our overall hedge fund sentiment score for CTXR is 59.2. Web20 hours ago · Citius Pharmaceuticals (CTXR) (Real Time Quote from BATS) $1.54 USD -0.03 (-1.91%) Updated Apr 13, 2024 02:16 PM ET Add to portfolio Zacks Rank: 4-Sell 4 Style Scores: F Value C Growth D... WebMay 6, 2024 · Additional sites to support trial completion by end of 2024. CRANFORD, N.J. , May 6, 2024 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR ), a late-stage ... birch and blush